Basic Information
| LncRNA/CircRNA Name | DLX6-AS1 |
| Synonyms | NA |
| Region | GRCh38_7:96955141-97014065 |
| Ensemble | ENSG00000231764 |
| Refseq | NR_015448 |
Classification Information
| Regulatory Mechanism | Biological Function | Clinical Application | |||
|---|---|---|---|---|---|
| TF | Immune | Survival | |||
| Enhancer | Apoptosis | apoptosis | Drug | ||
| Variant | Cell Growth | Circulating | |||
| MiRNA | EMT | Metastasis | |||
| Methylation | Coding Ability | Recurrence |
Cancer&Entry Information
| Cancer Name | neuroblastoma |
| ICD-0-3 | NA |
| Methods | qPCR, Western blot, Luciferase reporter assay etc. |
| Sample | NB tissues,cell lines (NB-1643, NB-1691, SK-N-AS, IMR-32, SH-SY5Y and SK-N-SH) |
| Expression Pattern | up-regulated |
| Function Description | DLX6-AS1 expression is upregulated in NB. |
| Pubmed ID | 31787850 |
| Year | 2019 |
| Title | Long noncoding RNA DLX6-AS1 promotes neuroblastoma progression by regulating miR-107/BDNF pathway |
External Links
| Links for DLX6-AS1 | GenBank HGNC NONCODE |
| Links for neuroblastoma | OMIM COSMIC |